ANALYSIS OF VACCINE AND ANTITOXIN PRODUCTION ALTERNATIVES

File: 110596_sep96_decls19_0001.txt
Page: 0001
Total Pages: 2

Subject: ANALYSIS OF VACCINE AND ANTITOXIN PRODUCTION  ALTERNATIVES      

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003203

Folder Title: INFORMAL STUDY GUIDANCE FOR COST BENEFIT ANALYSIS                                               

Document Number:          1

Folder SEQ  #:         79








                                                        Informal Study Guidance
                                                                   for
                                 CDst-Benefit Analysis of Vaccine and Antitoxin Production Alternatives


                Purpose

                7be analysis will provide a basis for Comparing alternative approaches to the Production of biological
                agent vaccines and anti-toxins for U.S. military personnel Mx rwwts of tlds awysis wiU be briefed
                to the USEKA&ID at the next review of the Biological Defmw Progmm. The rwwts of the analysis
                should resolve the following issues for the DeparuncnVs senior decision makers:

                         6       Should the Department of Defense develop, build, and operate a vaccine and antitoxin
                                 production facility?

                         0       What is the most cost effective method for pmducing biological agents and antitoxins
                                 for U.S. military pcrsomcl?

                         0       Besides costs, what am the most significant factors for deciding on- a method for
                                 vaccine ai                                     @r"i
                         .       What wein                                      D4rt St n (ODS) and to what extent
                                 are the cu                                     i insurhig imbat and medical readiness
                                 for future,


                         .       What is the value added to military medical preparedness by eidw a dual-use
                                 commercial or government owned facility over con           pmduction?

                         .       is the @d $2]OM production facility               y costed?

                Alternatives to be Compared

                         0       Present commercially co          (short tem) pmduction and stomge.

Long term wwor expanded commercially con@ production and storage.

                         0       A govenunent-owned oW operated production f=Uty.

                         0       A joint civilian and milituy dual-use facility.

                Assumptions and Co@nts

                         Mm analysis will be a odmpmbensive texmd report (wt a scripted briefmg) of the ftftgs of
                the wwysis team. Mw study should be consistent widi the following assumptions and                 ts:

                                 Medical couritermmm mored twlude both v                  and owtoxiiis.

                                 Storage and shelf-life of vaccines and antitoxins must be considered.





                                                                                                                          jLt

Document 2 f:/Week-36/BX003203/INFORMAL STUDY GUIDANCE FOR COST BENEFIT ANALYSIS/analysis of vaccine and antitoxin production al:11049609101920
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = INFORMAL STUDY GUIDANCE FOR COST BENEFIT ANALYSIS
Folder Seq # = 79
Subject = ANALYSIS OF VACCINE AND ANTITOXIN PRODUCTION AL
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 04-NOV-1996